Adenomyosis in subfertile women: pathophysiology and treatment options

In: Doctoral thesis, UCL (University College London). · 2026 · W7223478287
OA: green CC0
📄 Open PDF Full text JSON View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-10-26 ⓘ

This thesis quantified adenomyosis's negative impact on IVF outcomes, identified disordered uterine peristalsis as a potential mechanism, and evaluated GnRHa downregulation while initiating the MODA trial to test treatment efficacy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-26 · read from full text ⓘ

This doctoral thesis investigates the pathophysiology of adenomyosis in subfertile women, specifically examining its impact on IVF outcomes and potential mechanisms such as disordered uterine peristalsis. A retrospective cohort study revealed that live birth rates are lower in women with both adenomyosis and endometriosis compared to those with endometriosis alone, suggesting adenomyosis impairs implantation via uterus-specific processes rather than oocyte quality. The research further developed a novel ultrasound tool to quantify reduced coordination in uterine peristaltic waves among women with moderate to severe adenomyosis, while also highlighting the need for high-quality evidence regarding GnRHa downregulation treatments. This paper is centrally about adenomyosis — specifically exploring its mechanism of impaired implantation through altered uterine peristalsis and evaluating treatment options for subfertile patients.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is a common but incompletely characterised uterine disorder in which endometrial glands and stroma are found within the myometrium, and it is associated with reduced implantation, clinical pregnancy and live birth rates following in vitro fertilisation (IVF). Its diagnosis and severity classification remain contested, the mechanism by which it impairs implantation is unresolved, and the evidence base for treating affected women before embryo transfer is correspondingly inconsistent. In this thesis I therefore explored the pathophysiology of adenomyosis in subfertile women and examined treatment options for affected women undergoing IVF treatment. My overall objective was to quantify the effect of adenomyosis on reproductive outcome, to identify a mechanism through which that effect operates, and to test a treatment directed at that mechanism, on the hypothesis that adenomyosis impairs implantation through uterus-specific processes of which disordered uterine peristalsis is a measurable and potentially modifiable component. The research was structured around five key studies designed to address critical knowledge gaps and improve clinical outcomes in this population First, I conducted a retrospective cohort study evaluating the impact of coexisting adenomyosis and endometriosis on IVF/ICSI outcomes. This study, comprising 388 IVF/ICSI cycles in 187 women, demonstrated that live birth rates in women with both adenomyosis and endometriosis were lower than in women with endometriosis alone but comparable to those in women with adenomyosis alone. Embryo quality was comparable across groups, which is consistent with any effect of adenomyosis on reproductive outcome operating at the level of the uterus rather than the oocyte. To better understand this interaction, I undertook a narrative review of the literature on endometriosis and its impact on oocyte and embryo quality. The review confirmed that, although endometriosis has been associated with some alterations in the follicular microenvironment and oocyte competence, most studies including large meta-analyses have not demonstrated a significant negative impact on IVF/ICSI outcomes. Embryo morphology, implantation and live birth rates remain largely comparable between women with and without endometriosis when using assisted reproduction techniques. This raises the possibility that the adverse reproductive outcomes observed in women with both adenomyosis and endometriosis are primarily driven by adenomyosis and supports the hypothesis that adenomyosis compromises implantation through uterus-specific mechanisms, warranting targeted investigation into its underlying pathophysiology. In the subsequent study I examined the role of altered uterine peristalsis as a potential mechanism of infertility in women with adenomyosis. To do this, I developed a novel, objective tool to quantitatively assess uterine peristalsis on transvaginal ultrasound using an algorithm based on optical flow for motion quantification and validated it for inter- and intra-observer reproducibility for image acquisition. Inter- and intra-observer reproducibility was assessed for image acquisition; offline segmentation and optical flow analysis were performed by a single operator and were not subject to reproducibility testing. I applied this tool in a prospective study of 66 women with either moderate or severe adenomyosis or a normal uterus. Throughout the work in this thesis adenomyosis was diagnosed on transvaginal ultrasound using sonographic features consistent with the Morphological Uterus Sonographic Assessment (MUSA) consensus terminology (Van den Bosch et al., 2015; Harmsen et al., 2022), graded using the feature count described by Naftalin et al. (2012). The results demonstrated reduced coordination of uterine peristaltic waves in women with adenomyosis throughout the IVF cycle. This finding suggests that disordered uterine peristalsis may represent a disease-specific mechanism of impaired implantation and subfertility, and a potential target for therapeutic intervention. Building on these findings, I undertook a systematic review and meta-analysis to evaluate the evidence supporting prolonged gonadotrophin-releasing hormone analogue (GnRHa) downregulation prior to IVF/ICSI in women with adenomyosis, given the increase in recent data on this topic. The review included over 2,400 women across eight retrospective studies. Although several of these studies reported improved implantation and clinical pregnancy outcomes, the review concluded that the overall benefit remains uncertain due to methodological limitations and significant heterogeneity. These findings highlight the pressing need for high-quality, prospective randomised evidence to guide clinical decision-making. To address this, I designed, initiated, and currently lead the MODA trial (Modified Downregulation for Women with Adenomyosis), a multi-centre, prospective randomised controlled trial comparing six versus one week of GnRHa downregulation prior to frozen embryo transfer in women with moderate to severe adenomyosis. To date, 74 participants have been randomised. This work has encompassed the full clinical trial lifecycle: from conceptualising the research question, designing the protocol, securing ethics and regulatory approvals, and conducting site feasibility, capacity and capability assessments, to coordinating trial implementation across three fertility centres. I present the proposed statistical analysis plan and critically reflect on the real-world methodological challenges and key lessons learned from delivering a complex interventional trial in the field of reproductive medicine. Together, these studies provide novel insights into the mechanisms underlying infertility in women with adenomyosis and offer an evidence-based foundation for optimising treatment strategies and informing future therapeutic trials in this population.
Full text 7,248 characters · extracted from oa-html · click to expand
Latif, Sania; (2026) Adenomyosis in subfertile women: pathophysiology and treatment options. Doctoral thesis (Ph.D), UCL (University College London). Preview | Text Latif_10231198_Thesis_sig_removed.pdf Download (34MB) | Preview | Abstract Adenomyosis is a common but incompletely characterised uterine disorder in which endometrial glands and stroma are found within the myometrium, and it is associated with reduced implantation, clinical pregnancy and live birth rates following in vitro fertilisation (IVF). Its diagnosis and severity classification remain contested, the mechanism by which it impairs implantation is unresolved, and the evidence base for treating affected women before embryo transfer is correspondingly inconsistent. In this thesis I therefore explored the pathophysiology of adenomyosis in subfertile women and examined treatment options for affected women undergoing IVF treatment. My overall objective was to quantify the effect of adenomyosis on reproductive outcome, to identify a mechanism through which that effect operates, and to test a treatment directed at that mechanism, on the hypothesis that adenomyosis impairs implantation through uterus-specific processes of which disordered uterine peristalsis is a measurable and potentially modifiable component. The research was structured around five key studies designed to address critical knowledge gaps and improve clinical outcomes in this population First, I conducted a retrospective cohort study evaluating the impact of coexisting adenomyosis and endometriosis on IVF/ICSI outcomes. This study, comprising 388 IVF/ICSI cycles in 187 women, demonstrated that live birth rates in women with both adenomyosis and endometriosis were lower than in women with endometriosis alone but comparable to those in women with adenomyosis alone. Embryo quality was comparable across groups, which is consistent with any effect of adenomyosis on reproductive outcome operating at the level of the uterus rather than the oocyte. To better understand this interaction, I undertook a narrative review of the literature on endometriosis and its impact on oocyte and embryo quality. The review confirmed that, although endometriosis has been associated with some alterations in the follicular microenvironment and oocyte competence, most studies including large meta-analyses have not demonstrated a significant negative impact on IVF/ICSI outcomes. Embryo morphology, implantation and live birth rates remain largely comparable between women with and without endometriosis when using assisted reproduction techniques. This raises the possibility that the adverse reproductive outcomes observed in women with both adenomyosis and endometriosis are primarily driven by adenomyosis and supports the hypothesis that adenomyosis compromises implantation through uterus-specific mechanisms, warranting targeted investigation into its underlying pathophysiology. In the subsequent study I examined the role of altered uterine peristalsis as a potential mechanism of infertility in women with adenomyosis. To do this, I developed a novel, objective tool to quantitatively assess uterine peristalsis on transvaginal ultrasound using an algorithm based on optical flow for motion quantification and validated it for inter- and intra-observer reproducibility for image acquisition. Inter- and intra-observer reproducibility was assessed for image acquisition; offline segmentation and optical flow analysis were performed by a single operator and were not subject to reproducibility testing. I applied this tool in a prospective study of 66 women with either moderate or severe adenomyosis or a normal uterus. Throughout the work in this thesis adenomyosis was diagnosed on transvaginal ultrasound using sonographic features consistent with the Morphological Uterus Sonographic Assessment (MUSA) consensus terminology (Van den Bosch et al., 2015; Harmsen et al., 2022), graded using the feature count described by Naftalin et al. (2012). The results demonstrated reduced coordination of uterine peristaltic waves in women with adenomyosis throughout the IVF cycle. This finding suggests that disordered uterine peristalsis may represent a disease-specific mechanism of impaired implantation and subfertility, and a potential target for therapeutic intervention. Building on these findings, I undertook a systematic review and meta-analysis to evaluate the evidence supporting prolonged gonadotrophin-releasing hormone analogue (GnRHa) downregulation prior to IVF/ICSI in women with adenomyosis, given the increase in recent data on this topic. The review included over 2,400 women across eight retrospective studies. Although several of these studies reported improved implantation and clinical pregnancy outcomes, the review concluded that the overall benefit remains uncertain due to methodological limitations and significant heterogeneity. These findings highlight the pressing need for high-quality, prospective randomised evidence to guide clinical decision-making. To address this, I designed, initiated, and currently lead the MODA trial (Modified Downregulation for Women with Adenomyosis), a multi-centre, prospective randomised controlled trial comparing six versus one week of GnRHa downregulation prior to frozen embryo transfer in women with moderate to severe adenomyosis. To date, 74 participants have been randomised. This work has encompassed the full clinical trial lifecycle: from conceptualising the research question, designing the protocol, securing ethics and regulatory approvals, and conducting site feasibility, capacity and capability assessments, to coordinating trial implementation across three fertility centres. I present the proposed statistical analysis plan and critically reflect on the real-world methodological challenges and key lessons learned from delivering a complex interventional trial in the field of reproductive medicine. Together, these studies provide novel insights into the mechanisms underlying infertility in women with adenomyosis and offer an evidence-based foundation for optimising treatment strategies and informing future therapeutic trials in this population. | Type: | Thesis (Doctoral) | |---|---| | Qualification: | Ph.D | | Title: | Adenomyosis in subfertile women: pathophysiology and treatment options | | Open access status: | An open access version is available from UCL Discovery | | Language: | English | | Additional information: | Copyright © The Author 2026. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/deed.en). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. | | UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health | | URI: | https://discovery.ucl.ac.uk/id/eprint/10231198 | Archive Staff Only | View Item |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-11-16T06:03:07.005966+00:00
License: CC0 · commercial use OK